Suspected mpox admissions to a dedicated infectious-diseases isolation ward in northeastern Nigeria, 2022-2025: a register-based descriptive study with evidence of a household cluster
This register-based descriptive study of 15 suspected mpox admissions at a northeastern Nigerian hospital between 2022 and 2025 identified a significant household cluster and a 20% case fatality rate, highlighting the urgent need for strengthened laboratory diagnosis and mandatory result recording to improve surveillance accuracy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the vast landscape of human health, some diseases are like familiar neighbors, while others are distant relatives that occasionally visit with alarming intensity. Mpox, an illness caused by a virus related to the one that caused smallpox, belongs to that second group. For decades, it was known to exist in parts of West and Central Africa, often moving from animals to people. However, in recent years, the virus has become more active, causing outbreaks that have drawn global attention. When people get sick with mpox, they often develop a painful rash and fever, symptoms that can look very similar to other common illnesses like chickenpox. This similarity makes it difficult for doctors to know exactly what they are treating without special laboratory tests. In many parts of the world, especially where resources are limited, doctors must rely on their clinical judgment and the records kept in hospitals to understand how the disease is moving through a community. These records, often just simple ledgers written by hand, become a crucial window into the health of a population, revealing patterns that might otherwise remain hidden.
In northeastern Nigeria, a team of researchers decided to look closely at these hospital records to understand what was happening with suspected cases of mpox. They focused on a specific isolation ward at a major teaching hospital in Yola, a place designed to keep patients with contagious diseases separate from the general public. The researchers examined every admission to this ward between early 2022 and early 2025 where a doctor had written down mpox as a possible diagnosis. They were not looking for confirmed cases, which would require a lab test, but rather for the people who were sick enough to be admitted and for whom the doctors suspected this virus might be the cause. By piecing together the ages, genders, and locations of these patients, along with when they arrived and what happened to them, the team built a picture of the disease's impact in this specific region.
The story that emerged from these records was one of a disease affecting a specific group of people at a specific time. Out of all the patients admitted to the isolation ward during those three years, fifteen were suspected of having mpox. This represented a small but significant portion of the total patients, about one in every twenty admissions. The people who fell ill were predominantly young men. Most of the patients were under the age of forty, and a striking number were children or teenagers. In fact, six out of the fifteen patients were children under the age of eighteen, and the majority of all patients were male. This gender imbalance was quite pronounced, with four men for every woman admitted.
The timing of these admissions told a clear story about when the disease was most active. The vast majority of the suspected cases arrived in 2022, with a sharp spike in July of that year. During that single month, six patients were admitted. This timing aligns with a period when the virus was known to be spreading more widely across Nigeria. However, the most revealing detail came from looking at who these patients were and where they lived. Among the six patients who arrived in July, four were children and adolescents from the same family, living in the same house in a local area just north of the city. They were admitted within a week of each other, suggesting that the virus had passed from one family member to another inside their home. This finding was important because it highlighted that, in this region, the disease was not just spreading through adult social networks, but was also moving quietly through households, affecting children.
The outcome for these patients was serious. Three of the fifteen people admitted died, which is a high number for such a small group. One of the deaths involved a man who had developed a severe form of the disease that affected his lungs, while another was a woman whose diagnosis was uncertain, as her symptoms looked like both chickenpox and mpox. The third patient died before they could even be treated, arriving at the hospital already deceased. The researchers were careful to note that this high death rate did not necessarily mean the virus itself was more deadly in this area than elsewhere. Instead, they explained that the hospital they studied was a referral center, meaning it received the sickest patients from a wide area. People with mild cases usually stayed home and never made it to this hospital. Furthermore, because many of these cases were never confirmed by a lab test, some of the people who died might have been suffering from a different illness entirely, such as severe chickenpox, which can look very similar to mpox.
The study also shed light on the challenges of diagnosing these illnesses in a resource-limited setting. In many cases, doctors had to make a best guess based on how the patient looked, because the tools to confirm the virus were not always available or the results did not get recorded in the patient's file. The researchers pointed out that in this part of Nigeria, it is common for patients to have symptoms that could be either mpox or chickenpox, and sometimes both. Without a clear test, it is hard to know exactly how many people truly had mpox versus how many had something else. This uncertainty makes it difficult to calculate the true danger of the virus, but it also shows why better testing is so urgently needed. The researchers suggested that hospitals should use existing machines, which are already used for other diseases like tuberculosis, to test for mpox as well. They also recommended that doctors should test for both mpox and chickenpox at the same time, rather than guessing which one it is.
Ultimately, this study provided a rare glimpse into the reality of a suspected mpox outbreak in a part of the world where data is often scarce. It showed that the virus was affecting young men and children, that it could spread within families, and that it caused severe illness requiring hospital care. While the high number of deaths was alarming, the researchers explained that it likely reflected the severity of the cases that reached the hospital and the difficulty in telling different diseases apart, rather than a new, deadlier strain of the virus. The most important takeaway was the need for better tools to identify the virus quickly and accurately. By improving how hospitals record and test for these illnesses, health workers can better understand the true scope of the problem and protect the communities that are most at risk. The story of these fifteen patients is a reminder that even in the absence of perfect data, the simple act of keeping careful records can reveal vital truths about the health of a population.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.